AFP and cholangiocarcinoma: In our cHCC-CC cohort, AFP was recorded for 29 patients pre-treatment with 8 patients having an AFP > 100 ng/ml and 7 patients had CA19.9 recorded pre-treatment, with 4 of those patients having an elevated CA19.9.